A trial found six weeks of yoga improved sleep quality and reduced fatigue in people with MS, suggesting its use as a ...
Multiple sclerosis (MS) could be "on the brink of a new class of treatment" after early trial results suggest two drugs may repair damage caused by the condition. A study led by the University of ...
September and October 2025 have proven busy for multiple sclerosis (MS) professionals, as many gathered at three major conferences to discuss trials in the indication that could alter the current ...
Quantum BioPharma Ltd. has successfully completed its Phase 1 clinical trial of Lucid-21-302, also known as Lucid-MS, a novel compound aimed at treating multiple sclerosis (MS). A safety review ...
AUTOIMMUNE DISEASE WITH NO CURE, BUT UNMC IS AT THE FOREFRONT OF FINDING ONE. A GROUNDBREAKING CLINICAL TRIAL IS DOING SOMETHING NO ONE ELSE EVER HAS. IT APPEARS TO BE WORKING. KETV NEWSWATCH SEVEN’S ...
The first clinical data from an FDA-approved trial of a CAR T-cell therapy in the treatment of multiple sclerosis (MS) show the cells cause complete B-cell depletion, leading on to a reset of the ...
– Enrollment Completed for Both Phase 3 ENSURE Trials of Vidofludimus Calcium in Relapsing Multiple Sclerosis; Top-Line Data Expected End of 2026 – – Additional Data from Phase 2 CALLIPER Trial in ...
Long-term CNM-Au8 treatment demonstrated significant and clinically meaningful improvement of vision as measured by low contrast letter acuity (LCLA), an assessment of visual function in people living ...
Three investigators and their teams have received funding for clinical trial development projects as part of the International Progressive MS Alliance’s Experimental Medicine Trial Awards. These ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results